Parkinson’s disease Movement disordersDystoniaHeadacheAtaxiaInherited neurological disordersNon-cosmetic botulinum toxin therapy (Botox®)
Improving accuracy of diagnosis in Parkinson’s and related disordersDeveloping biomarkers to predict those at risk of Parkinson’s diseaseImproving clinical services for patients with Parkinson’s
Consultant Neurologist, Addenbrooke’s Hospital, Cambridge and West Suffolk Hospital, Bury St Edmunds
Fellow, Royal College of Physicians of LondonMember, Association of British NeurologistsMember, Clinical Studies Group, UK Dementia and Neurodegenerative Diseases Network (DeNDRoN)Research Director for Parkinson’s Disease, DeNDRoN East Anglia
Dr Worth is consultant in neurology at Addenbrooke’s Hospital in Cambridge and the West Suffolk Hospital in Bury St Edmunds. He trained in medicine at Cambridge and Oxford Universities and in neurology at the National Hospital for Neurology and Neurosurgery, London. His PhD was awarded after a period of 3 years as a MRC Clinical Training Fellow at the Institute of Neurology, London, for work on the genetics of Parkinson’s disease and cerebellar ataxias. He was appointed consultant neurologist in Norwich in 2004 where he led and developed the local clinical services for Parkinson’s which were cited on the Parkinson's UK website as an example of best practice. Here he pioneered a multidisciplinary team approach and recently developed an integrated care pathway for Parkinson’s. An important patient safety initiative was to set up a Parkinson’s medicines management team to address the problem of missed medication doses in hospital. He was ‘champion’ for the recent Parkinson’s Best Practice Tariff which incentivises hospitals to provide good care in accordance with NICE guidelines. His team was runner up in the Hospital Doctor Parkinson's Team of the Year Award in 2006. Dr Worth has given an address to MPs at the Palace of Westminster and was invited to give evidence to the All Party Parliamentary Group on inequalities of Parkinson’s services in 2009. He is a recognised expert and key opinion leader on advanced therapies for Parkinson’s, having published extensively in this area and having been one of the first neurologists in the UK to use Duodopa®. He teaches and lectures regularly on various aspects of Parkinson’s disease, dystonia, ataxia and other movement disorders at national and international meetings including the Royal Institution of Great Britain and is a faculty member of the Parkinson’s Academy. Dr Worth has led and taken part in numerous UK multi-centre and international research studies. He is Research Director for Parkinson’s in the Dementia and Neurodegenerative Disease Research Network, DeNDRoN East Anglia, and a member of the UK DeNDRoN Parkinson’s Clinical Studies Group.
Away from work, Dr Worth is a keen musician, enjoying the piano, guitar and singing. He is a cricket and rugby fanatic following the England teams wherever possible. He has a vintage campervan which absorbs many hours with tinkering and spontaneous weekends away. He enjoys cooking and entertaining, and spending time with his young family.
Use one or more of the options below to search for a consultant and link through to view their Spire profile.
fill out this form and we will get back to you:
Please select a hospital
Please enter your details below and we will call you back.
What is the aim of your enquiry?
If we are unable to reach you by phone, please include your email address so that we can get in touch...
© Spire Healthcare Group plc (2016)